News and updates
What changed in our tablet and provider coverage this week
A short update on recent tablet and provider comparison improvements and what readers can now check more easily.
Read article
News and blog
Weight-loss news and blog
UK weight-loss articles covering treatment routes, provider checks, costs, eligibility, NHS/private access and practical comparison questions. The focus is broad comparison context, not medicine-specific price tables.
Treatment route explainers
Provider comparison context
Costs, eligibility and safety
41published articles
8topic areas
UKcomparison focus
Latest article
Newest weight-loss comparison update
Fresh reading on provider checks, treatment routes, cost context and practical comparison questions.
Recent articles
More UK weight-loss guides and updates
Read across provider services, treatment routes, costs, support models and access questions without turning the hub into a medicine-specific price table.
Semaglutide and heart-risk guidance: why the 2026 NICE update matters
NICE’s 2026 semaglutide recommendation is not just a weight-loss story. It shows why indication, eligibility and context matter.
26 May 2026 · 2 min read
Questions to ask when a provider page still feels light on detail
A practical checklist for readers who find one provider page thin on detail and want a better comparison method.
25 May 2026 · 2 min read
NHS weight-management injections in 2026: what private comparison readers should know
NHS and private access routes can look similar in search results, but eligibility, rollout and assessment can differ significantly.
24 May 2026 · 2 min read
Generic semaglutide in Canada: what it does and does not mean for the UK
Canada has approved generic semaglutide injections, but that does not mean a generic Wegovy route or new UK provider access is here. This is what the change actually means.
23 May 2026 · 3 min read
Retatrutide Weight Loss Trial Results: What the New Eli Lilly Data Could Mean in the UK
Retatrutide delivered strong late-stage weight loss results, but it is not approved for routine UK prescribing. Here is what the new Eli Lilly data means and what to watch next.
23 May 2026 · 4 min read How to compare delivery, support and follow-up after the first prescription is considered
A practical guide to comparing what happens after assessment, including delivery, contact routes and follow-up support.
22 May 2026 · 2 min read
Online pharmacy weight-loss checks: what UK guidance means for users
Online pharmacy weight-loss services should involve more than a simple form. This guide explains the checks users may see and why they matter.
21 May 2026 · 2 min read
This week’s comparison update: where the parent site now sends Wegovy, Mounjaro and tablet questions
An update on how the parent site now routes broader questions into the right specialist comparison without losing the educational overview.
20 May 2026 · 2 min read
Medicine-specific comparison: when to use specialist Wegovy or Mounjaro sites
When broad comparison is enough, and when detailed Wegovy or Mounjaro provider tables are better handled by specialist sites.
19 May 2026 · 1 min read
Topics
Explore weight-loss articles by topic
Each topic supports a different part of the comparison journey: route choice, costs, provider checks, NHS/private access, safety and oral treatment options.
News and updates
17 articles
Updates that connect current news back to careful treatment, provider, cost and safety comparison.
Provider checks 13 articlesPractical checks for provider identity, assessment details, contact methods, support models and review dates.
Comparison basics 8 articlesPlain-English help for understanding what a comparison page is showing, what to verify and where deeper treatment detail belongs.
Tablets and capsules 7 articlesArticles focused on tablet and capsule comparisons, including pack size, access type, medicine identity and provider details.
Costs 5 articlesCost explainers that look beyond the headline number at dose, pack, delivery, support and details that can change.
Treatment News 4 articlesPublisher updates and explainers linked to careful treatment and provider comparison.
Safety checks 3 articlesSafety-first reading on legitimacy, regulated supply, clinical assessment and questions worth checking before going further.
NHS and private access 2 articlesGuidance on NHS and private access, including timing, eligibility context and how the pathway can differ.